VCAM1 and lung cancer: On the other hand, domain 6 of VCAM-1 appears to be a key target for TNFα-induced angiogenesis [31], and the antibody blockade of domain 6 impairs leukocyte transmigration but not adhesion, as well as lung cancer cell migration [3,6,32].